These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18292232)

  • 1. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
    Zarnegar B; Yamazaki S; He JQ; Cheng G
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3503-8. PubMed ID: 18292232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
    He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
    J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
    Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
    Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
    Kung CP; Raab-Traub N
    J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
    Farhana L; Dawson MI; Murshed F; Fontana JA
    Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The noncanonical NF-κB pathway.
    Sun SC
    Immunol Rev; 2012 Mar; 246(1):125-40. PubMed ID: 22435551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
    He JQ; Zarnegar B; Oganesyan G; Saha SK; Yamazaki S; Doyle SE; Dempsey PW; Cheng G
    J Exp Med; 2006 Oct; 203(11):2413-8. PubMed ID: 17015635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    Yang CH; Murti A; Pfeffer LM
    J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
    Demchenko YN; Glebov OK; Zingone A; Keats JJ; Bergsagel PL; Kuehl WM
    Blood; 2010 Apr; 115(17):3541-52. PubMed ID: 20053756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
    Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
    Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
    J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
    Liao G; Zhang M; Harhaj EW; Sun SC
    J Biol Chem; 2004 Jun; 279(25):26243-50. PubMed ID: 15084608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR; Siebenlist U
    J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
    Annunziata CM; Davis RE; Demchenko Y; Bellamy W; Gabrea A; Zhan F; Lenz G; Hanamura I; Wright G; Xiao W; Dave S; Hurt EM; Tan B; Zhao H; Stephens O; Santra M; Williams DR; Dang L; Barlogie B; Shaughnessy JD; Kuehl WM; Staudt LM
    Cancer Cell; 2007 Aug; 12(2):115-30. PubMed ID: 17692804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
    Saitoh T; Nakayama M; Nakano H; Yagita H; Yamamoto N; Yamaoka S
    J Biol Chem; 2003 Sep; 278(38):36005-12. PubMed ID: 12840022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
    Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.